BLT 0.00% 2.6¢ benitec biopharma limited

Clinical data required for a deal?, page-11

  1. 2,381 Posts.
    lightbulb Created with Sketch. 10
    Who cares, the patents will expire in a couple a years, well before there will be any therapeutic available. The only people to make any serious money out these shRNA patents are the lawyers. No wonder people hate them.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.